Friday, July 31, 2026

Kim Jong Un Visits New Destroyer Without Daughter Ju Ae, Raising Questions Over Her Reduced Public Profile

Kim Jong Un's daughter Ju Ae has been absent from public events, raising speculation about North Korea's succession plans and propaganda strategies.

16-Year Old’s Fate in Balance After Attack on Rep. Bae Hyun Jin

A South Korean court will announce the verdict for a student charged with attacking Rep. Bae Hyun Jin, focusing on mental capacity claims.

1500th Mass for Korean Reconciliation: A Historic Step Towards Peace

The Catholic Archdiocese of Seoul celebrated its 1,500th Mass for Korean reconciliation, emphasizing peace between North and South Korea.

Tag: cancer

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

GIST Maps Out the Cascade of Cellular Interactions During Early Stages of Lung Cancer

South Korean researchers unveil how mutated cells create a cancer-friendly environment in early lung cancer, paving the way for early interventions.

SCL Group Partners with Indonesian Hospital to Expand Into Southeast Asia

SCL Group partners with Indonesia's RSCM Hospital to expand Korean-style precision diagnostics in Southeast Asia, focusing on cancer screening and AI solutions.

Unlocking Cancer Treatment: Celltrion’s 4 Promising ADC Drugs Enter Patient Trials in 2026

Celltrion's ADC cancer drug candidates CT-P70, CT-P71, and CT-P73 enter patient dosing, targeting various cancers with Fast Track Designation.

Nesuparib: The Revolutionary Dual-Inhibitor for Pancreatic Cancer – Can It Outperform Existing Treatments?

Nesuparib shows promise in inhibiting pancreatic cancer metastasis, offering hope for patients regardless of BRCA mutation status.

Lunit’s AI-based bile duct cancer study selected for rapid oral presentation at U.S. oncology conference

Lunit will present five research abstracts at ASCO 2026, showcasing the expanding role of AI biomarkers in cancer treatment.

Verismo unveils preclinical data on improved antitumor efficacy and safety of blood cancer CAR-T at AACR

HLB Innovation's SynKIR-310 shows improved antitumor activity and safety in preclinical trials, achieving 100% survival in mice.

Stage 3 lung cancer patients over 70 can receive “active treatment” so “should not give up”

A study shows elderly patients (70+) with stage 3 lung cancer can complete standard treatment, challenging age-related treatment hesitance.

ABL209: The Promising Dual Antibody ADC Revolutionizing Cancer Treatment in 2026

ABL Bio's ABL209 shows promising anti-cancer effects with broad safety in preclinical studies, advancing to Phase 1 trials in the U.S.

Unlocking Triple Negative Breast Cancer: How Gene-Protein Analysis Predicts Treatment Success

A study reveals that analyzing genetic and protein data can predict chemotherapy effectiveness in triple-negative breast cancer, aiding personalized treatment.

Nesuparib: The Game-Changing Cancer Treatment for Small Cell Lung Cancer Revealed at AACR 2026

Onconic Therapeutics reveals Nesuparib's promising preclinical results for small cell lung cancer, outperforming existing treatments significantly.

Celltrion sees prescription growth for key products in Europe, raises expectations for high-margin new drugs

Celltrion's cancer and autoimmune disease treatments are achieving stable growth in Europe, expanding their market influence.

Coreline Soft Secures Major AI Contract with Italy’s National Cancer Center for Lung Cancer Early Detection

Coreline Soft renews its contract for AVIEW LCS Plus with Italy's National Cancer Center, enhancing early lung cancer diagnosis via AI.

Next-Gen Cancer Drug Nesuparib: How It Outperforms Olaparib in SCLC and Pancreatic Cancer

Onconic Therapeutics will present Nesuparib research at AACR 2026, showcasing its potential for various cancers and overcoming PARP inhibitor limitations.

Samsung Bioepis Launches SBE303: The First ADC Drug Candidate Targeting Nectin-4 in Cancer Trials

Samsung Bioepis has begun Phase 1 trials for its ADC candidate SBE303, targeting solid tumors, set to continue until July 2030.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.